Clinical Trials Logo

Neurofibromatosis 1 clinical trials

View clinical trials related to Neurofibromatosis 1.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT02589912 No longer available - Clinical trials for Neurofibromatosis Type 2

Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients

Start date: n/a
Phase:
Study type: Expanded Access

The Nucleus 24 Auditory Brainstem Implant (ABI) is the only FDA approved device for restoration of meaningful hearing in Neurofibromatosis Type 2 (NF2) patients. This device has been discontinued, meaning that there is no commercially approved device currently available. The replacement model, the ABI541 (an unapproved device), is being investigated in ongoing clinical trials. A compassionate use arm of a clinical trial allows patients with NF2 to be implanted with this new ABI.